nach oben

Current Rheumatology Reports

Erschienen in:

09.02.2022 | Vasculitis (C Dejaco and C Duftner, Section Editors)

Idiopathic Orbital Myositis Revisited

verfasst von: Ilse Mombaerts, Alan A. McNab

Erschienen in: Current Rheumatology Reports | Ausgabe 1/2022

Einloggen, um Zugang zu erhalten

Abstract

Purpose of Review

To review current knowledge regarding idiopathic orbital myositis.

Recent Findings

Recent publications have focused on possible causes of orbital myositis and the process to reach a diagnosis of idiopathic orbital myositis. With inflamed and enlarged extraocular muscles, features to distinguish between competing diagnostic possibilities are based on imaging in the context of history and clinical signs. Idiopathic orbital myositis is characterized by the clinical triad of acute onset of orbital pain exacerbated on eye movement, double vision, and redness or swelling of the eyelids or conjunctiva, along with the radiological finding of homogeneous, fusiform enlargement of one or more extraocular muscles. In atypical or inconclusive clinico-radiological findings for a diagnosis of idiopathic orbital myositis, or where the clinical behavior changes or fails to respond to corticosteroid treatment, a systemic and oncologic work-up and muscle biopsy are warranted to exclude specific local or systemic disease as cause of the inflamed and enlarged muscle.

Summary

As our understanding of idiopathic orbital myositis evolves, the diagnostic focus is shifting toward earlier identification of underlying local or systemic disease through systemic work-up and muscle biopsy.

Verma M, Fitzpatrick K, McLoon LK. Extraocular muscle repair and regeneration. Curr Ophthalmol Rep. 2017;5:207–15. https://doi.org/10.1007/s40135-017-0141-4.CrossRefPubMedPubMedCentral

Yu Wai Man CY, Chinnery PF, Griffiths PG. Extraocular muscles have fundamentally distinct properties that make them selectively vulnerable to certain disorders. Neuromuscular disorders 2005;15:17–23. https://doi.org/10.1016/j.nmd.2004.10.002.

McNab AA. Orbital myositis: a comprehensive review and reclassification. Ophthalmic Plast Reconstr Surg. 2020;36:109–17. https://doi.org/10.1097/IOP.0000000000001429. Comprehensive review of the various causes of orbital myositis emphasizing the need of a systematic approach to nomenclature, diagnosis and treatment.CrossRefPubMed

Gleason JE. Idiopathic myositis involving the extraocular muscles. Am J Ophthalmol. 1903;12:471–8.

Birsh-Hirschfeld A. Zur diagnostik und pathologie der orbital-tumoren. Ber Dtsch Ophthalmol Ges. 1905;32:127–35.

Mombaerts I, Goldschmeding R, Schlingemann RO, Koornneef L. What is orbital pseudotumor? Surv Ophthalmol. 1996;4:66–78. https://doi.org/10.1016/s0039-6257(97)81996-0.CrossRef

Mannor GE, Rose GE, Moseley IF, Wright JE. Outcome of orbital myositis clinical features associated with recurrence. Ophthalmology. 1997;104:409–14. https://doi.org/10.1016/s0161-6420(97)30300-5.CrossRefPubMed

Mombaerts I, Koornneef L. Current status in the treatment of orbital myositis. Ophthalmology. 1997;104:402–8. https://doi.org/10.1016/s0161-6420(97)30301-7.CrossRefPubMed

Kang MS, Yang HK, Kim N, Hwang JM. Clinical features of ocular motility in idiopathic orbital myositis. J Clin Med. 2020;18(9):1165. https://doi.org/10.3390/jcm9041165.CrossRef

10.

Jakobiec FA, Syed ZA, Stagner AM, Harris GJ, Rootman J, Yoon MK, et al. Orbital inflammation in pregnant women. Am J Ophthalmol. 2016;166:91–102. https://doi.org/10.1016/j.ajo.2016.03.029.CrossRefPubMed

11.

Scott IU, Siatkowski RM. Idiopathic orbital myositis. Curr Opinion. Rheumatol. 1997;9:504–12. https://doi.org/10.1097/00002281-199711000-00005.CrossRef

12.

Yan JY, Wu P. Idiopathic orbital myositis. J Craniofac Surg. 2014;25:884–7. https://doi.org/10.1097/SCS.0000000000000510.CrossRefPubMed

13.

Avni-Zauberman N, Tripathy D, Rosen N, Ben Simon GJ. Relapsing migratory idiopathic orbital inflammation: six new cases and review of the literature. Br J Ophthalmol. 2012;96:276–80. https://doi.org/10.1136/bjo.2010.191866.CrossRefPubMed

14.

Siatkowski RM, Capo H, Byrnse SF, Gendron EK, Flynn JT, Muñoz M, et al. Clinical and echographic findings in idiopathic orbital myositis. Am J Ophthalmol. 1994;118:343–50. https://doi.org/10.1016/s0002-9394(14)72959-9.CrossRefPubMed

15.

Ben Artsi E, McKelvie PA, McNab AA. Histopathological findings in idiopathic orbital myositis. Ophthalmology. 2021;128:609–16. https://doi.org/10.1016/j.ophtha.2020.09.012. Rare case study on the histopathological spectrum of idiopathic orbital myositis.CrossRefPubMed

16.

Mombaerts I, Tousseyn T, Van Limbergen E, Demaerel P. Clinically recognizing enlarged extraocular muscles from lymphoid origin. Ophthalmology. 2015;122:217–8. https://doi.org/10.1016/j.ophtha.2014.08.018.CrossRefPubMed

17.

Moorman CM, Elston JS. Acute orbital myositis Eye. 1995;9:96–101. https://doi.org/10.1038/eye.1995.15.CrossRefPubMed

18.

Osher RH, Schatz NJ, Duane TD. Acquired orbital retraction syndrome. Arch Ophthalmol. 1980;98:1798–802. https://doi.org/10.1001/archopht.1980.01020040650012.CrossRefPubMed

19.

Patrinely JR, Osborn AG, Anderson RL, Whiting AS. Computed tomographic features of nonthyroid extraocular muscle enlargement. Ophthalmology. 1989;96:1038–47. https://doi.org/10.1016/s0161-6420(89)32785-0.CrossRefPubMed

20.

Mombaerts I, Rose GE, Verity DH. Diagnosis of enlarged extraocular muscles: when and how to biopsy. Curr Opin Ophthalmol. 2017;28:514–21. https://doi.org/10.1097/ICU.0000000000000395.CrossRefPubMed

21.

Boonman ZF, De Keizer RJ, Graniewski-Wijnands HS, Watson PG. Orbital myositis in scleritis. Br J Ophthalmol. 2003;87:38–42. https://doi.org/10.1136/bjo.87.1.38.CrossRefPubMedPubMedCentral

22.

Fatima Z, Ichikawa T, Ishigame K, Motosugi U, Waqar AB, Hori M, et al. Orbital masses: the usefulness of diffusion-weighted imaging in lesion categorization. Clin Neuroradiol. 2014;24:129–34. https://doi.org/10.1007/s00062-013-0234-x.CrossRefPubMed

23.

Hu H, Xu XQ, Liu H, Hong XN, Shi HB, Wu FY. Orbital benign and malignant lymphoproliferative disorders: differentiation using semi-quantitative and quantitative analysis of dynamic contrast-enhanced magnetic resonance imaging. Eur J Radiol. 2017;88:88–94. https://doi.org/10.1016/j.ejrad.2016.12.03.CrossRefPubMed

24.

Laban KG, Kalmann R, Leguit RJ. de Keizer B 2019 Zirconium-89-labelled rituximab PET-CT in orbital inflammatory disease. EJNMMI Res. 2019;9:1–7. https://doi.org/10.1186/s13550-019-0530-9. Pilot study on a novel B-cell imaging method in patients with non-specific and specific orbital inflammatory disease.CrossRef

25.

Eade EL, Hardy TG, McKelvie PA, McNab AA. Review of extraocular muscle biopsies and utility of biopsy in extraocular muscle enlargement. Br J Ophthalmol. 2018;102:1586–90. https://doi.org/10.1097/IOP.0000000000001426. Large case study on biopsy-proven benign and malignant extraocular muscle disease, highlighting the need of muscle biopsy.CrossRefPubMed

26.

Mombaerts I, Bilyk JR, Rose GE, McNab AA, Fay A, Dolman PJ, et al. Consensus on diagnostic criteria of idiopathic orbital inflammation using a modified Delphi approach. JAMA Ophthalmol. 2017;135:769–76. https://doi.org/10.1001/jamaophthalmol.2017.1581.CrossRefPubMedPubMedCentral

27.

Mombaerts I, Ramberg I, Coupland SE, Heegaard S. Diagnosis of orbital mass lesions: clinical, radiological, and pathological recommendations. Surv Ophthalmol. 2019;64:741–56. https://doi.org/10.1016/j.survophthal.2019.06.006. Review of the diagnostic algorithm of orbital mass lesions with emphasis on the tissue biopsy.CrossRefPubMed

28.

Selva D, Dolman PJ, Rootman J. Orbital granulomatous giant cell myositis: a case report and review. Clin Exp Ophthalmol. 2000;28:65–8. https://doi.org/10.1046/j.1442-9071.2000.00273.x.CrossRefPubMed

29.

Kattah JC, Zimmerman LE, Kolsky MP, Chrousos G, Chavis R, Jaffe G, et al. Bilateral orbital involvement in fatal giant cell polymyositis. Ophthalmology. 1990;97:520–5. https://doi.org/10.1016/s0161-6420(90)32554-x.CrossRefPubMed

30.

Armstrong BK, Murchison AP, Bilyk JR. Suspected orbital myositis associated with COVID-19. Orbit. 2021;40:532–5. https://doi.org/10.1080/01676830.2021.1962366.CrossRefPubMed

31.

Vargason CW, Mawn LA. Orbital myositis as both a presenting and associated extraintestinal sign of Crohn’s disease. Ophthalmic Plast Reconstr Surg. 2017;33(3S Suppl 1):S158–60. https://doi.org/10.1097/IOP.0000000000000475.CrossRefPubMed

32.

Glass LRD, Freitag SK. Orbital inflammation: corticosteroids first. Surv Ophthalmol. 2016;6:670–3. https://doi.org/10.1016/j.survophthal.2016.01.005.CrossRef

33.

Leibovitch I, Prabhakaran VC, Davis G, Selva D. Intraorbital injection of triamcinolone acetonide in patients with idiopathic orbital inflammation. Arch Ophthalmol. 2007;125:1647–51. https://doi.org/10.1001/archopht.125.12.1647.CrossRefPubMed

34.

Smith JR, Rosenbaum JT. A role for methotrexate in the management of non-infectious orbital inflammatory disease. Br J Ophthalmol. 2001;85:1220–4. https://doi.org/10.1136/bjo.85.10.1220.CrossRefPubMedPubMedCentral

35.

Lee MJ, Planck SR, Choi D, Harrington CA, Wilson DJ, Dailey RA, et al. Non-specific orbital inflammation: current understanding and unmet needs. Prog Retin Eye Res. 2021;81:100885. https://doi.org/10.1016/j.preteyeres.2020.100885. Comprehensive overview of the current state of clinical knowledge regarding non-specific orbital inflammation.CrossRefPubMed

36.

Garrity JA, Coleman AW, Matteson EL, Eggenberger ER, Waitzman DM. Treatment of recalcitrant idiopathic orbital inflammation (chronic orbital myositis) with infliximab. Am J Ophthalmol. 2004;138:925–30. https://doi.org/10.1016/j.ajo.2004.06.077.CrossRefPubMed

37.

Meca Casasnovas N, Sangrador Pelluz C, Sotoca J. Tocilizumab as an alternative for corticosteroid-refractory orbital myositis. J Neuroimmunol. 2021;356: 577573. https://doi.org/10.1016/j.jneuroim.2021.577573.CrossRefPubMed

38.

Isobe K, Uno T, Kawakami H, Ueno N, Kawata T, Abe H, et al. Radiation therapy for idiopathic orbital myositis: two case reports and literature review. Radiat Med. 2004;22:429–31.PubMed

39.

Bessant DA, Lee JP. Management of strabismus due to orbital myositis. Eye (Lond). 1995;9(Pt 5):558–63. https://doi.org/10.1038/eye.1995.139.CrossRef

Titel: Idiopathic Orbital Myositis Revisited
verfasst von: Ilse Mombaerts
Alan A. McNab
Publikationsdatum: 09.02.2022
Verlag: Springer US
Erschienen in: Current Rheumatology Reports / Ausgabe 1/2022
Print ISSN: 1523-3774
Elektronische ISSN: 1534-6307
DOI: https://doi.org/10.1007/s11926-022-01052-y

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

„Überwältigende“ Evidenz für Tripeltherapie beim metastasierten Prostata-Ca.

22.05.2024 Prostatakarzinom Nachrichten

Patienten mit metastasiertem hormonsensitivem Prostatakarzinom sollten nicht mehr mit einer alleinigen Androgendeprivationstherapie (ADT) behandelt werden, mahnt ein US-Team nach Sichtung der aktuellen Datenlage. Mit einer Tripeltherapie haben die Betroffenen offenbar die besten Überlebenschancen.

So sicher sind Tattoos: Neue Daten zur Risikobewertung

22.05.2024 Melanom Nachrichten

Das größte medizinische Problem bei Tattoos bleiben allergische Reaktionen. Melanome werden dadurch offensichtlich nicht gefördert, die Farbpigmente könnten aber andere Tumoren begünstigen.

CAR-M-Zellen: Warten auf das große Fressen

22.05.2024 Onkologische Immuntherapie Nachrichten

Auch myeloide Immunzellen lassen sich mit chimären Antigenrezeptoren gegen Tumoren ausstatten. Solche CAR-Fresszell-Therapien werden jetzt für solide Tumoren entwickelt. Künftig soll dieser Prozess nicht mehr ex vivo, sondern per mRNA im Körper der Betroffenen erfolgen.

Frühzeitige HbA1c-Kontrolle macht sich lebenslang bemerkbar

22.05.2024 Typ-2-Diabetes Nachrichten

Menschen mit Typ-2-Diabetes von Anfang an intensiv BZ-senkend zu behandeln, wirkt sich positiv auf Komplikationen und Mortalität aus – und das offenbar lebenslang, wie eine weitere Nachfolgeuntersuchung der UKPD-Studie nahelegt.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen